CR Bard (BCR) a Strong Buy on Top-End Quant Score

Currently, CR Bard Inc (NYSE:BCR) has a Strong Buy using the system of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 3 months.

BCR ranks in the top decile in its industry group, Health Care Equipment & Supplies, and in the top decile of sector group, Health Care, with a market value of $24.2 billion.

Portfolio Grader currently ranks the Health Care sector number 9 among the 12 sectors in its universe putting it in the bottom quartile of all the GICS sectors. The Health Care Equipment & Supplies industry group is ranked 38 among the 69 industry groups within the GICS sectors, placing it below-average in terms of the Navellier scoring system.

BCR has received well above-average scores in 1, and above-average scores in 0 of the 8 fundamental areas appraised by Portfolio Grader in the ranking of company stocks.

BCR's operational scores are below the industry norms for sales growth, operating margin, and earnings growth. Scores for visibility of earnings are worse than the industry norms for earnings revisions, earnings surprises, and earnings momentum. BCR's ranking for return on equity is decidedly better than its industry group average but its grade for cash flow is below-average. Based on these fundamental scores, CR Bard places in the top half of the industry group.

Quantitatively, Portfolio Grader uses the Navellier Proprietary Quantitative Score to measure BCR's shares from the aspect of risk/reward. This unique scoring system considers the relative value of the company's shares based on the current price of the shares relative to its peers, the market and risk associated with its industry and sector groups. Considering this risk/reward calculation, BCR currently scores well above-average in its industry group compared to its peers.

Louis Navellier's proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results, with A being 'strong buy' and F being 'strong sell'. Explore the tool here.

Commentary provided by UpTick Data Technologies.


Article printed from InvestorPlace Media, https://investorplace.com/2017/11/cr-bard-bcr-a-strong-buy-on-top-end-quant-score-2/.

©2026 InvestorPlace Media, LLC